| ABOUT BAYBIOGET INVOLVEDEVENT CENTER
MEMBER CENTERINFORMATION CENTERMEDIA CENTERCAREER CENTER |
Opportunities while Navigating the Financial Crisis: Sponsored by:
![]() The economic landscape has changed dramatically over the course of the past six months. As funding has become more difficult to obtain, executives must making tough choices regarding priorities and the allocation of resources. Companies are feeling increased pressure to meet the expectations of shareholders, and the ever-present hand of government regulations continues to evolve and change. Still, in this atmosphere of doom and gloom there are plenty of success stories - a number of Northern California companies have completed record breaking financial deals. What strategies did CEOs and CFOs employ to successfully secure funding? What insights charted their course? What are they doing to manage shareholder expectations? Join several CEO and CFO teams from leading life sciences companies for an interactive session, to hear their war stories and industry insights. Discussion Anchors: Paul Hastings Chief Executive Officer, Oncomed Pharmaceuticals William Waddill Sr. Vice President, Chief Financial Officer, Oncomed Pharmaceuticals John Hollway Interim Chief Financial Officer, Achaogen Inc. Hoyoung Huh Chief Executive Officer, BiPar Sciences, Inc. Leo Redmond Chief Financial Officer, Presidio Pharmaceuticals, Inc. Moderator: Carole-Lynn Glass Director Emerging Growth Services, RoseRyan, Inc. br>
Admission to this event is open to life sciences company executives by invitation only. To attend, please send your request to events@baybio.org. No on-site registration will be provided to this event
Is your company a member? Click here to check. See how your company can save money by becoming a BayBio member! |